id: sud_treatment_facility_density_to_prenatal_substance_exposure
name: SUD Treatment Facility Density â†’ Prenatal Substance Exposure
from_node:
  node_id: sud_treatment_facility_density
  node_name: SUD Treatment Facility Density
to_node:
  node_id: prenatal_substance_exposure
  node_name: Prenatal Substance Exposure
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Limited number of buprenorphine treatment clinics exist in region (490 total in North Carolina)'
- 'Step 2: Of responding clinics, only 34% accepted pregnant patients during pandemic'
- 'Step 3: Geographic distribution creates treatment deserts for pregnant individuals with OUD'
- 'Step 4: Inability to access medication treatment results in continued opioid use during pregnancy'
- 'Step 5: Ongoing opioid use leads to prenatal substance exposure affecting fetal development'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Ashley C. Lensch et al. 2021. "Pregnant Patients Using Opioids: Treatment Access
    Barriers in the Age of COVID-19." https://doi.org/10.1097/ADM.0000000000000826'
  supporting_citations:
  - SAMHSA treatment locator data used as sampling frame
  - Additional citations require full-text access
  - Additional citations require full-text access
  doi: 10.1097/ADM.0000000000000826
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Low density of SUD treatment facilities accepting pregnant patients (only 34% during pandemic)
  creates structural barriers to care that increase risk of prenatal substance exposure. Treatment service
  limitations (45% prescribe naltrexone, 57% offer detoxification) further restrict therapeutic options.
quantitative_effects:
  effect_size:
    value: 34.0
    type: percentage_change
  sample_size: 128
spatial_variation:
  varies_by_geography: true
  variation_notes: Study sampled every sixth clinic in North Carolina from SAMHSA locator; geographic
    distribution of accepting clinics not detailed but likely creates rural-urban disparities
moderators:
- name: Detoxification availability
  direction: weakens
  strength: weak
  description: Only 57% of accepting clinics offered detoxification with opioid agonists, further limiting
    treatment options
- name: Naltrexone prescribing
  direction: weakens
  strength: weak
  description: Only 45% of accepting clinics prescribed naltrexone, limiting medication options for some
    patients
structural_competency:
  equity_implications: This mechanism illustrates how healthcare infrastructure decisions at the policy
    and institutional level determine access to evidence-based treatment for pregnant individuals with
    OUD. The structural exclusion of pregnant patients from OUD treatment represents a systemic failure
    that leads to preventable prenatal exposures and adverse birth outcomes. Policy interventions requiring
    treatment facilities to serve pregnant populations would address this structural barrier.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.204262'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
